ReWalk Robotics Ltd. (NASDAQ:LFWD) Director Joseph E. Turk, Jr. Purchases 6,000 Shares

ReWalk Robotics Ltd. (NASDAQ:LFWD) Director Joseph E. Turk, Jr. bought 6,000 shares of the firm’s stock in a transaction that occurred on Friday, December 13th. The shares were purchased at an average cost of $1.69 per share, for a total transaction of $10,140.00. Following the completion of the transaction, the director now owns 18,516 shares of the company’s stock, valued at $31,292.04. This represents a 47.94 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

ReWalk Robotics Trading Down 0.7 %

NASDAQ:LFWD opened at $1.49 on Friday. The stock has a market cap of $13.12 million, a price-to-earnings ratio of -0.60 and a beta of 2.04. The stock has a 50-day moving average price of $2.13 and a two-hundred day moving average price of $3.16. ReWalk Robotics Ltd. has a 1 year low of $1.41 and a 1 year high of $9.10.

ReWalk Robotics (NASDAQ:LFWD) last announced its quarterly earnings results on Tuesday, November 12th. The company reported ($0.35) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.08). ReWalk Robotics had a negative net margin of 77.21% and a negative return on equity of 43.02%. The company had revenue of $6.13 million during the quarter, compared to the consensus estimate of $8.38 million. During the same period in the previous year, the firm posted ($0.56) EPS. Sell-side analysts forecast that ReWalk Robotics Ltd. will post -1.78 earnings per share for the current year.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in ReWalk Robotics stock. Dimensional Fund Advisors LP acquired a new position in shares of ReWalk Robotics Ltd. (NASDAQ:LFWD) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 13,548 shares of the company’s stock, valued at approximately $54,000. Dimensional Fund Advisors LP owned approximately 0.16% of ReWalk Robotics as of its most recent SEC filing. Hedge funds and other institutional investors own 26.76% of the company’s stock.

Analyst Ratings Changes

Separately, HC Wainwright restated a “buy” rating and set a $13.00 target price on shares of ReWalk Robotics in a report on Wednesday, November 13th.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.